Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-023 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to establish collaborations between liver cancer investigators and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded Liver Cirrhosis Network (LCN) members to advance our understanding of hepatocellular carcinoma (HCC) as the result of liver cirrhosis and its etiologic risks, development, progression, early diagnosis, and treatment. The funds available through this FOA will support new multidisciplinary liver cance...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 30, 2023 Category: Research Source Type: funding
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-084 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 21, 2022 Category: Research Source Type: funding
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-083 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 21, 2022 Category: Research Source Type: funding
Genomic Data Analysis Network: Genomic Data Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-20-053 from the NIH Guide for Grants and Contracts. Projects to be Served by Pipeline The proposed analytical network will serve to understand the data generated by CCG programs as well as collaborations with other divisions: The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST) Exceptional Responders (ER, in collaboration with DCTD) Clinical Trials Sequencing Program (CTSP, in collaboration with DCTD) Carcinomas of Unknown Primary (CUPP) Refractory Cancers (Peripheral T-Cell Lymphomas, Recurrent GBMs) This resource that can be utilized by any NCI p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 4, 2020 Category: Research Source Type: funding
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-678 from the NIH Guide for Grants and Contracts. The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2018 Category: Research Source Type: funding
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-677 from the NIH Guide for Grants and Contracts. The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2018 Category: Research Source Type: funding
A Pilot Partnership to Find Private Support for Unfunded Applications
When I was an editor at JAMA, we often considered papers that were strong, received favorable reviews, and yet could not be published for lack of space. As it turned out, we had an option other than outright rejection: we could offer authors a user-friendly pathway by which their papers, and the reviews that went with them, could be forwarded for consideration at another journal (e.g. JAMA Internal Medicine). Later, when I came to NIH I wondered whether it was even theoretically possible for a funding agency to do something similar: arrange a way for highly meritorious but unfunded projects to find their way to willing, ev...
Source: NIH Extramural Nexus - March 23, 2016 Category: Research Authors: Mike Lauer Tags: blog Open Mike General New Resources OnPAR public-private partnership Source Type: funding
National Pancreas Foundation Research Grant Program
Applications are due by January 30, 2015. The National Pancreas Foundation (NPF) is a private, non-profit organization established to support the funding of research related to pancreatic diseases. It also provides support for the men, women, and children who are suffering from diseases of the pancreas. Eligibility Applicants must be employed by an institution engaged in health related research. The applicant further must agree to be supervised by the institution at all times while conducting research supported by the NPF. In cases of a change in institutions while applying for, or utiliz...
Source: ScanGrants feed - November 18, 2014 Category: Research Authors: National Pancreas Foundation Source Type: funding
American Gastroenterological Association-R. Robert & Sally Funderburg Research Award in Gastric Cancer
American Gastroenterological Association-R. Robert & Sally Funderburg Research Award in Gastric Cancer This award is made to support the research of an established investigator working on novel approaches to gastric cancer. Eligibility: Established Investigators Total Amount: $100,000 Amount per year: $50,000 Duration: Two years Deadline: Aug. 29, 2014 Start Date: Jan. 1, 2015 This award provides $50,000 per year for two years (total $100,000) to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology; regen...
Source: ScanGrants feed - August 4, 2014 Category: Research Authors: American Gastroenterological Association Source Type: funding
National Pancreas Foundation Research Grant Program
Applications are due January 8, 2014 Eligibility Applicants must be employed by an institution engaged in health related research within the United States. The applicant further must agree to be supervised by the institution at all times while conducting research supported by the NPF. In cases of a change in institutions while applying for, or utilizing funds from the NPF, applicants must notify the NPF, and will be subject to review based upon the change in circumstances. The research must be in the field of pancreatic diseases. Studies intended to advance knowledge in the areas of pancreatic ...
Source: ScanGrants feed - December 11, 2013 Category: Research Authors: National Pancreas Foundation Source Type: funding
Funderburg Research Award in Gastric Cancer
One award is made to support the research of an established investigator working on novel approaches to gastric cancer. Eligibility: Established Investigators Total Amount: $100,000 Amount per year: $50,000 Duration: 2 years Deadline: Aug. 30, 2013 Start Date: Jan. 1, 2014 This award provides $50,000 per year for two years (total $100,000) to an established investigator working on novel approaches in gastric cancer research, including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (i...
Source: ScanGrants feed - July 10, 2013 Category: Research Authors: American Gastroenterological Association Research Foundation Source Type: funding
